Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001418850> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2001418850 abstract "S S3 Unmet needs related to quality of life: Questionnaire-based survey in a breast cancer patient follow-up program S.D. Soysal, A. Posabella*, S. Muenst, C.T. Viehl, A. Imgraben, D. Oertli, R. Rosenthal, R. Zanetti, W.P. Weber 1 Breast Center, University Hospital Basel, Basilea, Switzerland Division of Visceral Surgery, St. Clara Hospital, Basilea, Switzerland Division of Surgery, Biel Hospital, Biel, Switzerland * Corresponding author: Alberto Posabella, Division of Visceral Surgery, St. Clara Hospital, Basilea, Switzerland. E-mail address: alberto.posabella@libero.it (A. Posabella) Study objective: Breast cancer is the most frequent malignancy in Swiss women constituting 32% of all cancer cases. Early detection of locoregional recurrence during routine follow-up seems to have an impact on survival. Numerous studies have assessed different strategies for post-operative follow-up, including timing of clinical exams and imaging, but few of them have analyzed the impact of follow-up on patient’s quality of life and how patient preferences could be integrated into current follow-up strategies. The aim of our study was to detect unmet needs in breast cancer breast cancer patients concerning their follow-up. Materials and methods: All patients that were followed after breast cancer surgery at our department during a 1 year period were asked to complete a standardized questionnaire including 44 questions on different aspects of follow-up. Main results: 84% of patients completed the questionnaire. Even though 79% of patients were satisfied overall with the current follow up, 87% stated that the follow-up visits were not comprehensive enough. 53% of breast cancer patients stated that they were not fully aware of the rationale to perform routine follow-up. 68% of patients assumed that the main aim was the detection of cancer recurrence, while 13% and 30% thought the aim was the detection of side effects or the prevention and control of anxiety, respectively. Interestingly, 16% of patients stated that more routine visits increased their anxiety, whereas 65% were reassured by these visits. 94% of patients expected to attend regular visits for an unlimited time period, whereas only 5% expected them to continue for ten additional years. 60% of patients wish that their family members should be included in the follow-up visits. Of note, 81% of patients agree that a breast care nurse coordinates the follow-up visits. Conclusion: The present results show that previous standards in breast cancer follow-up did not fully meet patient needs, and that not all patients are fully aware of the cause and duration of follow-up visits. As a consequence of this study, a more significant role has be assigned to a specialized breast care nurse in our institution, coordinating the multidisciplinary approach and remaining the reference contact for patients. Additionally, patients are informed more comprehensively and special attention is given to their requests. http://dx.doi.org/10.1016/j.ejso.2014.10.008 The role of sentinel node biopsy in breast cancer patients treated with neoadjuvant chemotherapy S. Mocellin*, E. Goldin, A. Marchet, D. Nitti Departments of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy * Corresponding author: Simone Mocellin, Universit a di Padova, Padova, Italy. E-mail address: simone.mocellin@unipd.it (S. Mocellin) Study objective: Sentinel lymph node biopsy (SNB) is considered a standard procedure for the treatment of patients with early-stage breast cancer, with a high detection rate and low false negative rate. However, the use of SNB for staging the axilla of patients with advanced breast cancer after neoadjuvant chemotherapy (NAC) is still controversial. The purpose of this study is to determine the feasibility and accuracy of sentinel lymph node biopsy in this group of patients through the analysis of data obtained both from our own experience as well as those published in the international scientific literature. Material and methods: In the first part of the study, we analyzed data from 131 patients who had received NAC. In 37 patients who underwent axillary lymph node dissection and subsequent SNB we calculated the rate of sentinel node identification (SIR) and the false negative rate (FNR). In the second part of the study we performed a systematic review of the literature by searching the Medline database. Collected data were used to perform a meta-analysis of the available evidence for both SIR and FNR using the random-effect model. Between-study heterogeneity was quantified using the I-squared statistic and its significance assessed by the Cochran Q-test. Main results: In 37 patients who underwent NAC followed by sentinel node biopsy and axillary dissection, the SIR was 92.6% (95% CI: 82.1e97.9) and the FNR was 10.5% (95% CI: 1.3e33.1). Fifty-seven studies enrolling 6,414 patients were included in the meta-analysis. The SIR ranged between 71% and 100%, while the FNR between 0% and 39%. The estimated summary SIR was 89.7% (95% CI: 87.8e91.4; Isquared: 77.2%, Q-test P-value 90%) and FNR (<10%), the results of our study and meta-analysis of the literature show that SNB performed after NAC is feasible, although its accuracy is suboptimal, suggesting some caution in its implementation in the routine clinical setting. The substantial heterogeneity of the published findings emphasizes the need to identify subgroups of patients in whom the SNB might be more accurate and therefore more reliable in this setting. http://dx.doi.org/10.1016/j.ejso.2014.10.009 Microwave ablation with AMICA probe for unresectable locally advanced pancreatic cancer. Quality of life and performance status. V. Sciascia*, A. Febbraro, G. Benincasa, E. Di Gaeta, G. Perillo, D.M. Marra, L. Festa, L. Pascale, G. Ambrosino 1 Department of Surgical Oncology and Laparoscopic Surgery, NEUROMED IRCCS, Malzoni Group, Avellino, Italy Department of Oncology, Fatebenefratelli Hospital, Benevento, Italy Department of Surgical Pathology, NEUROMED IRCCS, Malzoni Group, Avellino, Italy Department of Radiology, NEUROMED IRCCS, Malzoni Group, Avellino, Italy 5 Intensive Care Unit, NEUROMED IRCCS, Malzoni Group, Avellino, Italy * Corresponding author: Valerio Sciascia, Department of Surgical Oncology and Laparoscopic Surgery, NEUROMED IRCCS, Malzoni Group, Avellino, Italy. E-mail address: valerio.sciascia@gmail.com (V. Sciascia) Study objectives: Data on safety and efficacy related to microwave ablation (MWA) of locally advanced pancreatic cancer are scarce and may need further studies. The primary endpoint of our study was to evaluate Quality of Life (QoL) and Performance Status (PS) and the second endpoint was to evaluate feasibility, morbidity and mortality after ablative treatment in patients affected by locally advanced pancreatic cancer. Material and method: Between January and June 2013, 16 patients affected by locally advanced pancreatic cancer underwent laparoscopic MWA in our department by means of AMICA probe. On admittance, all the patients (9 men vs. 7 women) were evaluated with a PS questionnaire, whole-body contrast-enhanced CT scan and US-guided percutaneous biopsy. The patients underwent a follow-up three-times a week in the first month and a weekly control for two months thereafter. On day 90 a second assessment questionnaire was submitted to compare QoL" @default.
- W2001418850 created "2016-06-24" @default.
- W2001418850 creator A5004115234 @default.
- W2001418850 creator A5008871195 @default.
- W2001418850 creator A5008894098 @default.
- W2001418850 creator A5027754950 @default.
- W2001418850 creator A5044265747 @default.
- W2001418850 creator A5045265664 @default.
- W2001418850 creator A5052142072 @default.
- W2001418850 creator A5052275469 @default.
- W2001418850 creator A5057556096 @default.
- W2001418850 date "2015-01-01" @default.
- W2001418850 modified "2023-09-23" @default.
- W2001418850 title "Unmet needs related to quality of life: Questionnaire-based survey in a breast cancer patient follow-up program" @default.
- W2001418850 doi "https://doi.org/10.1016/j.ejso.2014.10.008" @default.
- W2001418850 hasPublicationYear "2015" @default.
- W2001418850 type Work @default.
- W2001418850 sameAs 2001418850 @default.
- W2001418850 citedByCount "0" @default.
- W2001418850 crossrefType "journal-article" @default.
- W2001418850 hasAuthorship W2001418850A5004115234 @default.
- W2001418850 hasAuthorship W2001418850A5008871195 @default.
- W2001418850 hasAuthorship W2001418850A5008894098 @default.
- W2001418850 hasAuthorship W2001418850A5027754950 @default.
- W2001418850 hasAuthorship W2001418850A5044265747 @default.
- W2001418850 hasAuthorship W2001418850A5045265664 @default.
- W2001418850 hasAuthorship W2001418850A5052142072 @default.
- W2001418850 hasAuthorship W2001418850A5052275469 @default.
- W2001418850 hasAuthorship W2001418850A5057556096 @default.
- W2001418850 hasConcept C121608353 @default.
- W2001418850 hasConcept C126322002 @default.
- W2001418850 hasConcept C144024400 @default.
- W2001418850 hasConcept C159110408 @default.
- W2001418850 hasConcept C2779951463 @default.
- W2001418850 hasConcept C36289849 @default.
- W2001418850 hasConcept C512399662 @default.
- W2001418850 hasConcept C530470458 @default.
- W2001418850 hasConcept C59364581 @default.
- W2001418850 hasConcept C71924100 @default.
- W2001418850 hasConcept C74909509 @default.
- W2001418850 hasConceptScore W2001418850C121608353 @default.
- W2001418850 hasConceptScore W2001418850C126322002 @default.
- W2001418850 hasConceptScore W2001418850C144024400 @default.
- W2001418850 hasConceptScore W2001418850C159110408 @default.
- W2001418850 hasConceptScore W2001418850C2779951463 @default.
- W2001418850 hasConceptScore W2001418850C36289849 @default.
- W2001418850 hasConceptScore W2001418850C512399662 @default.
- W2001418850 hasConceptScore W2001418850C530470458 @default.
- W2001418850 hasConceptScore W2001418850C59364581 @default.
- W2001418850 hasConceptScore W2001418850C71924100 @default.
- W2001418850 hasConceptScore W2001418850C74909509 @default.
- W2001418850 hasLocation W20014188501 @default.
- W2001418850 hasOpenAccess W2001418850 @default.
- W2001418850 hasPrimaryLocation W20014188501 @default.
- W2001418850 hasRelatedWork W106594936 @default.
- W2001418850 hasRelatedWork W11850704 @default.
- W2001418850 hasRelatedWork W1522445567 @default.
- W2001418850 hasRelatedWork W1965645973 @default.
- W2001418850 hasRelatedWork W1989132221 @default.
- W2001418850 hasRelatedWork W1995063681 @default.
- W2001418850 hasRelatedWork W2006524818 @default.
- W2001418850 hasRelatedWork W2050729176 @default.
- W2001418850 hasRelatedWork W2087190255 @default.
- W2001418850 hasRelatedWork W2121316249 @default.
- W2001418850 hasRelatedWork W2123605396 @default.
- W2001418850 hasRelatedWork W2163541856 @default.
- W2001418850 hasRelatedWork W2403260627 @default.
- W2001418850 hasRelatedWork W2414278444 @default.
- W2001418850 hasRelatedWork W2553976558 @default.
- W2001418850 hasRelatedWork W2560428855 @default.
- W2001418850 hasRelatedWork W3082491486 @default.
- W2001418850 hasRelatedWork W3092547647 @default.
- W2001418850 hasRelatedWork W3109320495 @default.
- W2001418850 hasRelatedWork W3134421448 @default.
- W2001418850 isParatext "false" @default.
- W2001418850 isRetracted "false" @default.
- W2001418850 magId "2001418850" @default.
- W2001418850 workType "article" @default.